Thus, the mechanisms by which cancer causes insulin resistance in vivo seem to be different from those causing insulin resistance in obesity and T2D, where muscle Akt and TBC1D4 signaling is either unaffected [49,50] or reduced [51,52]. Here, TBC1D4 is linked to Insulin resistance.